{"id":5977,"date":"2019-11-22T12:00:32","date_gmt":"2019-11-22T18:00:32","guid":{"rendered":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/?p=5977"},"modified":"2021-05-20T15:51:50","modified_gmt":"2021-05-20T20:51:50","slug":"identify-destroy-synergistic-pathogenic-biofilm-management","status":"publish","type":"post","link":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/2019\/11\/22\/identify-destroy-synergistic-pathogenic-biofilm-management\/","title":{"rendered":"Identify &#038; Destroy!  Synergistic Pathogenic Biofilm Management"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-6062 alignright\" src=\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2019\/11\/Win-Win-Blog-Image.png\" alt=\"\" width=\"450\" height=\"300\" srcset=\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2019\/11\/Win-Win-Blog-Image.png 630w, https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2019\/11\/Win-Win-Blog-Image-300x200.png 300w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<p>Synergy is the combined effect of two things being greater than either one independently. As a veteran of managing periodontal diseases, that is how I view salivary diagnostics and Guided Biofilm Therapy (GBT).\u00a0\u00a0 With salivary diagnostics I can identify specific pathogens thriving in my patient\u2019s biofilm, and through the process of GBT I am able to dismantle and destroy those pathogens.\u00a0 This is synergy at its best.<\/p>\n<p>Quick review of pathogenic biofilm, then we can focus on GBT and salivary diagnostics: When biofilm becomes pathogenic there is a shift that takes place creating an imbalance of specific bacteria in the biofilm, thereby making healthy biofilm inflammatory, and potentially destructive to oral and overall health in susceptible individuals.\u00a0\u00a0 I might suggest reading that last sentence again.\u00a0 It describes a process.\u00a0 This process doesn\u2019t unfold the same for everyone, and risk factors are as varied as the individuals.<\/p>\n<p>The challenge for dental professionals lies in the fact that no matter how we disrupt the biofilm, it starts re-organizing almost immediately.\u00a0 GBT encompasses several key aspects of managing the biofilm differently than traditional methods.\u00a0 First, biofilm removal is prioritized since that is what drives disease, and is performed early in the appointment, prior to the removal of hard deposits. Thoroughly removing biofilm first (with the use of disclosing agents) enables clinicians to more effectively see and feel remaining calcified deposits, thereby reducing repetitive strokes and preventing over-instrumentation.\u00a0 Most importantly, with GBT, biofilm is removed with the use of specific air polishing devices and specific powders that are safe for removal of biofilm on teeth, implants, inside periodontal pockets, and from delicate restorative materials. Erythritol in powder form is a powerful yet gentle agent to almost magically remove stains and adherent biofilms when used in AIRFLOW\u00ae air polishing devices. Remaining calcified deposits are easily removed with Piezo technology followed by site-specific hand instrumentation, as indicated.\u00a0 Managing biofilms with GBT is incredibly efficient, comfortable to the patient, and minimally invasive.<\/p>\n<p>Remember the shift I referred to earlier?\u00a0 What is it that promotes a change from a healthy biofilm to one that is pathogenic?\u00a0 Specific pathogens are implicated.\u00a0 Being able to test the saliva and identify the specific pathogens present completes the clinical picture, determines how at risk the patient is for disease, and what strategies might be necessary to modify the host response in order to return the biofilm to a healthy homeostasis. Sometimes, it is surprising to see the pathogen load of patients compared to the clinical signs of disease.\u00a0 They do not always match! We need to know what we\u2019re dealing with.<\/p>\n<p>Here is an example of this synergy in action.\u00a0 Hypothetical: Brad presents with moderate generalized bleeding and localized 4-5 mm pockets noted on posterior teeth. He is a periodontal maintenance patient, so subgingival calculus is minimal.\u00a0 Pathogenic biofilm, however, is prevalent.\u00a0 Brad is a cancer survivor and he wants to keep his teeth.\u00a0 Performing a MyPerioPath\u00ae test on Brad reveals he has Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn) above threshold levels.\u00a0 Pg is a key pathogen implicated in periodontal destruction and other adverse health outcomes, but both Pg and Fn have also been shown to <a href=\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/2019\/09\/06\/how-do-you-speak-risk-of-cancer-and-periodontal-disease-with-your-patients\/\">increase the risks for various forms of cancer<\/a>.\u00a0 A treatment plan for Brad that includes testing to identify what pathogens are culprits in his disease, coupled with a plan to dismantle and remove the biofilm subgingivally, sets this patient up for success.\u00a0 Performing re-evaluation salivary testing following active therapy helps clinicians ensure that dangerous periodontal pathogens have been diminished, or in some cases, identify next strategies necessary to accomplish the goal. If you are not currently identifying and attacking the enemy with a synergistic approach, perhaps it is time to reassess your strategies!<\/p>\n<p>For more information on how to become an OralDNA Provider \u2013 scan HERE:\u00a0<a href=\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2021\/05\/QR.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7542\" src=\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2021\/05\/QR.jpg\" alt=\"\" width=\"80\" height=\"80\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Managing biofilms with Guided Biofilm Therapy is incredibly efficient, comfortable to the patient, and minimally invasive. Being able to test the saliva and identify the specific pathogens present completes the clinical picture, determines how at risk the patient is for disease, and what strategies might be necessary to modify the host response in order to return the biofilm to a healthy homeostasis.<\/p>\n","protected":false},"author":28,"featured_media":6062,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[131,135,110],"tags":[9,170,136],"class_list":["post-5977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-technologies","category-oral-biofilm","category-salivary-diagnostics","tag-bacterial-testing","tag-new-technologies","tag-oral-biofilm"],"jetpack_featured_media_url":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2019\/11\/Win-Win-Blog-Image.png","jetpack_sharing_enabled":false,"jetpack_shortlink":"https:\/\/wp.me\/p7W16z-1yp","_links":{"self":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5977"}],"collection":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/comments?post=5977"}],"version-history":[{"count":9,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5977\/revisions"}],"predecessor-version":[{"id":7742,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5977\/revisions\/7742"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/media\/6062"}],"wp:attachment":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/media?parent=5977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/categories?post=5977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/tags?post=5977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}